Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| CDP-Choline (Citicoline) | DMAE (Dimethylaminoethanol) | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 250-500 mg/day | 150-400 mg/day (as DMAE bitartrate, typically 37% DMAE) |
| Timing | Morning or split morning/afternoon. With or without food. | Morning. With or without food. |
| Cycle Duration | Ongoing; no cycling required | Ongoing; no strict cycling required |
| Evidence Level | strong_human | animal_plus_anecdotal |
Prodrug that is hydrolyzed to choline and cytidine upon oral ingestion. Choline supports acetylcholine synthesis and phosphatidylcholine membrane repair. Cytidine is converted to uridine, which enhances synaptic membrane synthesis via the Kennedy pathway and upregulates dopamine receptor density. This dual mechanism — cholinergic support plus dopaminergic modulation — is unique among choline sources.
250-500 mg/day
Morning or split morning/afternoon. With or without food.
Ongoing; no cycling required
Structural analog of choline that crosses the BBB more readily than choline itself. Paradoxically increases choline availability not by serving as a direct precursor to acetylcholine, but by inhibiting choline metabolism in peripheral tissues, thereby increasing circulating choline available for brain uptake. Also acts as a free radical scavenger and membrane stabilizer. Reduces lipofuscin accumulation in neuronal cells, an age pigment associated with cellular aging.
150-400 mg/day (as DMAE bitartrate, typically 37% DMAE)
Morning. With or without food.
Ongoing; no strict cycling required
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →